D-0773-2016 Class III Terminated
FDA drug recall D-0773-2016 was initiated by Teva Pharmaceuticals USA on Nov 19, 2015 and is designated Class III. Reason for recall: Labeling: Not Elsewhere Classified: Lack of leaflets and approved labels on bottles. The recall status is terminated (terminated Nov 15, 2016). Affected quantity: 576 bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Mar 23, 2016
- Initiation Date
- Nov 19, 2015
- Termination Date
- Nov 15, 2016
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 576 bottles
Product description
NABUMETONE Tablets USP, 750 mg, 100 count bottle,Teva Pharmaceutical Industries Ltd., Jerusalem, 91010, ISRAEL
Reason for recall
Labeling: Not Elsewhere Classified: Lack of leaflets and approved labels on bottles.
Distribution pattern
Nationwide and Puerto Rico.
Code information
Lot #: 05N533, Exp 11/16
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0773-2016
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026